1. Medtech Insight
  2. >>Business

How A Pro-Software Patent Bill Could Affect The Medtech Industry

Though it didn’t even get to committee, a bill to make it easier for tech companies to patent software – including medical software – has a good chance of getting passed in Congress this year, bill proponents and legal experts say.

Balance in digital background. Concept of technology law, lawsuit, digital law, net neutrality

Draft legislation designed to make it easier for companies to gain patents for medical software is likely to make a comeback in the US Congress this year. Proponents of the bill say it will reverse a trend set by a six-year-old Supreme Court case that virtually made it impossible to get software patents.

In May 2019, Sens. Thom Tillis, R-NC, and Chris Coons, D-DE, as well as Reps. Doug Collins, R-GA, Hank Johnson,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

HistoSonics Sells Majority Stake To Investor Syndicate In Deal Valued At $2.25Bn

 
• By Marion Webb

HistoSonics’ CEO Michael Blue describes the deal as a win-win for all stakeholders and plans to use the money to expand clinical indications, as well as the global reach, for its Edison system.

Execs On The Move: July 28–August 1, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

PathAI Talks PCCPs: ‘Accelerated Software Updates, Saves Time And Money’

 
• By Natasha Barrow

The US FDA has authorized around 107 devices with Predetermined Change Control Plans in place, with PathAI's AISight Dx digital pathology image management system one of the latest. Medtech Insight talks to Eric Walk, chief medical officer, to find out about the process and its benefits.